Search Results - "Pearce, LA"

Refine Results
  1. 1

    Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular Atrial Fibrillation by CONWAY, Dwayne S. G, PEARCE, Lesly A, CHIN, Bernard S. P, HART, Robert G, LIP, Gregory Y. H

    Published in Circulation (New York, N.Y.) (01-07-2003)
    “…Abnormal plasma markers of a prothrombotic state have been described in atrial fibrillation (AF), but no such marker has yet been shown to reliably predict…”
    Get full text
    Journal Article
  2. 2

    Meta-analysis : Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation by HART, Robert G, PEARCE, Lesly A, AGUILAR, Maria I

    Published in Annals of internal medicine (19-06-2007)
    “…Atrial fibrillation is a strong independent risk factor for stroke. To characterize the efficacy and safety of antithrombotic agents for stroke prevention in…”
    Get full text
    Journal Article
  3. 3

    Independent predictors of stroke in patients with atrial fibrillation : A systematic review by Hart

    Published in Neurology (07-08-2007)
    “…Absolute stroke rates vary widely among patients with nonvalvular atrial fibrillation. To balance the benefits and risks of chronic antithrombotic prophylaxis,…”
    Get full text
    Journal Article
  4. 4

    Avoiding central nervous system bleeding during antithrombotic therapy : Recent data and ideas by HART, Robert G, TONARELLI, Silvina B, PEARCE, Lesly A

    Published in Stroke (1970) (01-07-2005)
    “…Approximately 7000 intracerebral hemorrhages (ICHs) annually in the US are caused by use of antithrombotic therapies. We review the incidence, risk factors,…”
    Get full text
    Journal Article
  5. 5

    Development and validation of health system performance measures for opioid use disorder in British Columbia, Canada by Nosyk, B., Min, JE, Pearce, LA, Zhou, H., Homayra, F., Wang, L., Piske, M., McCarty, D., Gardner, G., O’Briain, W., Wood, E., Daly, P., Walsh, T., Henry, B.

    Published in Drug and alcohol dependence (01-04-2022)
    “…Performance measurement provides an evidence-based means to inform development of interventions to improve the quality of care for people who use opioids. We…”
    Get full text
    Journal Article
  6. 6

    Determinants of selection into buprenorphine/naloxone among people initiating opioid agonist treatment in British Columbia by Homayra, F., Hongdilokkul, N., Piske, M., Pearce, L.A., Zhou, H., Min, J.E., Krebs, E., Nosyk, B.

    Published in Drug and alcohol dependence (01-02-2020)
    “…•Individual and provider factors influence buprenorphine/naloxone selection.•Provider-related differences accounted for 48.8 % of selection…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Antithrombotic therapy To prevent stroke in patients with atrial fibrillation : A meta-analysis by HART, R. G, BENAVENTE, O, MCBRIDE, R, PEARCE, L. A

    Published in Annals of internal medicine (05-10-1999)
    “…To characterize the efficacy and safety of anticoagulants and antiplatelet agents for prevention of stroke in patients with atrial fibrillation. Randomized…”
    Get full text
    Journal Article
  9. 9

    Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease by APPLE, Fred S, MURAKAMI, Maryann M, PEARCE, Lesly A, HERZOG, Charles A

    Published in Circulation (New York, N.Y.) (03-12-2002)
    “…This study determined the prevalence of increased cardiac troponin I (cTnI) and T (cTnT) in end-stage renal disease (ESRD) patients and whether an increased…”
    Get full text
    Journal Article
  10. 10

    Multi-Biomarker Risk Stratification of N-Terminal Pro-B-Type Natriuretic Peptide, High-Sensitivity C-Reactive Protein, and Cardiac Troponin T and I in End-Stage Renal Disease for All-Cause Death by Apple, Fred S, Murakami, MaryAnn M, Pearce, Lesly A, Herzog, Charles A

    Published in Clinical chemistry (Baltimore, Md.) (01-12-2004)
    “…In patients with end-stage renal disease (ESRD), the ability of single and multiple biomarker monitoring to predict adverse outcomes has not been well…”
    Get full text
    Journal Article
  11. 11

    An evaluation of Take Home Naloxone program implementation in British Columbian correctional facilities by Pearce, Lindsay A, Mathany, Lauren, Rothon, Diane, Kuo, Margot, Buxton, Jane A

    Published in International journal of prisoner health (11-03-2019)
    “…Purpose To understand how the Take Home Naloxone (THN) program is implemented in two pilot correctional facilities in British Columbia (BC), Canada, in order…”
    Get full text
    Journal Article
  12. 12

    Lessons from the Stroke Prevention in atrial fibrillation trials by HART, Robert G, HALPERIN, Jonathan L, PEARCE, Lesly A, ANDERSON, David C, KRONMAL, Richard A, MCBRIDE, Ruth, NASCO, Elaine, SHERMAN, David G, TALBERT, Robert L, MARLER, John R

    Published in Annals of internal medicine (20-05-2003)
    “…Atrial fibrillation predisposes to left atrial thrombus formation and carries a sixfold increased risk for stroke. Antithrombotic therapies are the mainstay…”
    Get full text
    Journal Article
  13. 13

    Factors Associated With Ischemic Stroke During Aspirin Therapy in Atrial Fibrillation: Analysis of 2012 Participants in the SPAF I–III Clinical Trials by Hart, Robert G., Pearce, Lesly A., McBride, Ruth, Rothbart, Robert M., Asinger, Richard W.

    Published in Stroke (1970) (01-06-1999)
    “…Background and Purpose —Nonvalvular atrial fibrillation (AF) is a strong, independent risk factor for stroke, but the absolute rate of stroke varies widely…”
    Get full text
    Journal Article
  14. 14

    Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy by Hart, Robert G, Pearce, Lesly A, Rothbart, Robert M, McAnulty, John H, Asinger, Richard W, Halperin, Jonathan L

    “…OBJECTIVE This study was performed to characterize the risk of stroke in elderly patients with recurrent intermittent atrial fibrillation (AF). BACKGROUND…”
    Get full text
    Journal Article
  15. 15

    Atrial fibrillation, stroke, and acute antithrombotic therapy: Analysis of randomized clinical trials by HART, Robert G, PALACIO, Santiago, PEARCE, Lesly A

    Published in Stroke (1970) (01-11-2002)
    “…Strokes in patients with atrial fibrillation (AF) are typically larger, are associated with higher early mortality, and occur in older patients versus strokes…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage by BAILEY, Renee D, HART, Robert G, BENAVENTE, Oscar, PEARCE, Lesly A

    Published in Neurology (27-03-2001)
    “…To characterize the rates of recurrent intracranial hemorrhage (ICH), ischemic stroke, and death in survivors of primary ICH. Systematic review of studies…”
    Get full text
    Journal Article
  18. 18

    Patients With Nonvalvular Atrial Fibrillation at Low Risk of Stroke During Treatment With Aspirin: Stroke Prevention in Atrial Fibrillation III Study by Anderson, David C, Halperin, Jonathan L, Hart, Robert G, McAnulty, John H

    “…CONTEXT.— Nonvalvular atrial fibrillation (AF) carries an increased risk for stroke, but absolute rates of stroke vary widely within the broad spectrum of AF…”
    Get full text
    Journal Article
  19. 19

    Transesophageal Echocardiographic Correlates of Clinical Risk of Thromboembolism in Nonvalvular Atrial Fibrillation by Zabalgoitia, Miguel, Halperin, Jonathan L, Pearce, Lesly A, Blackshear, Joseph L, Asinger, Richard W, Hart, Robert G

    “…Objectives. This study explored the mechanisms linking clinical and precordial echocardiographic predictors to thromboembolism in atrial fibrillation (AF) by…”
    Get full text
    Journal Article
  20. 20